{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T09:47:27Z","timestamp":1774000047991,"version":"3.50.1"},"reference-count":72,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Non-alcoholic fatty liver disease (NAFLD) constitutes a significant global health burden with rising prevalence. While Traditional Chinese Medicine (TCM) exhibits growing potential in NAFLD intervention, no domain-specific bibliometric evaluation currently exists. Utilising the most recent data from authoritative bibliographic databases, this study conducts a comprehensive bibliometric analysis to delineate the knowledge structure, research fronts, and collaborative networks in this field.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We searched for publications from 2000 to 2024 in the Web of Science Core Collection (WoSCC) database, encompassing a total of 855 papers. In addition, a supplementary search was conducted in the PubMed database to identify and analyze eligible clinical trials. Bibliometric analyses were performed utilising R software, VOSviewer, and CiteSpace.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Investigations into TCM about NAFLD have indicated a general upward trajectory. China leads in research output, succeeded by the United States and South Korea. Shanghai University of Traditional Chinese Medicine is the preeminent cooperative institution. Ji G ranks as the most productive author in this field, whereas Younossi ZM emerges as the most frequently co-cited scholar. Among journals, Journal of Ethnopharmacology publishes the largest number of articles, while Hepatology receives the highest citation frequency. Key research themes include gut microbiota, network pharmacology, inflammation, insulin resistance, and lipid metabolism. Research hotspots primarily concentrate on the mechanisms by which TCM compounds, like berberine and Lingguizhugan Decoction, have garnered considerable attention, and the utilisation of contemporary research methodologies, such as network pharmacology, has markedly intensified.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This bibliometric analysis thoroughly outlines the current status and developmental tendencies of TCM research in NAFLD for the first time, offering significant references for future investigations in this domain.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1744929","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T06:36:46Z","timestamp":1773988606000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Mapping the knowledge domain: a bibliometric analysis of global research on traditional Chinese medicine for non-alcoholic fatty liver disease (2000\u20132024)"],"prefix":"10.3389","volume":"13","author":[{"given":"Zhongwen","family":"Feng","sequence":"first","affiliation":[{"name":"Centre for Artificial Intelligence Driven Drug Discovery, Faculty of Applied Sciences, Macao Polytechnic University","place":["Macau, Macao SAR, China"]},{"name":"Department of Pharmacy, Guangxi Academy of Medical Sciences and the People's Hospital of Guangxi Zhuang Autonomous Region","place":["Nanning, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingliu","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Guangxi Academy of Medical Sciences and the People's Hospital of Guangxi Zhuang Autonomous Region","place":["Nanning, China"]},{"name":"Pharmaceutical College, Guangxi Medical University","place":["Nanning, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinglian","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Nursing, Guangxi Academy of Medical Sciences and the People\u2019s Hospital of Guangxi Zhuang Autonomous Region","place":["Nanning, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuefeng","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Guangxi Academy of Medical Sciences and the People's Hospital of Guangxi Zhuang Autonomous Region","place":["Nanning, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunyun","family":"Qin","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Guangxi Academy of Medical Sciences and the People's Hospital of Guangxi Zhuang Autonomous Region","place":["Nanning, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kefeng","family":"Li","sequence":"additional","affiliation":[{"name":"Centre for Artificial Intelligence Driven Drug Discovery, Faculty of Applied Sciences, Macao Polytechnic University","place":["Macau, Macao SAR, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyu","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Guangxi Academy of Medical Sciences and the People's Hospital of Guangxi Zhuang Autonomous Region","place":["Nanning, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,20]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1111\/apt.17833","article-title":"Global perspective on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis - prevalence, clinical impact, economic implications and management strategies","volume":"59","author":"Golabi","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"103910","DOI":"10.1016\/j.drudis.2024.103910","article-title":"Nafld and Nash: etiology, targets and emerging therapies","volume":"29","author":"Wei","year":"2024","journal-title":"Drug Discov Today"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1002\/hep.31150","article-title":"Epidemiological features of Nafld from 1999 to 2018 in China","volume":"71","author":"Zhou","year":"2020","journal-title":"Hepatology"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.jhep.2023.04.036","article-title":"Changing epidemiology, global trends and implications for outcomes of Nafld","volume":"79","author":"Wong","year":"2023","journal-title":"J Hepatol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of Nafld development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/hc9.0000000000000251","article-title":"The burden of nonalcoholic fatty liver disease (Nafld) is rapidly growing in every region of the world from 1990 to 2019","volume":"7","author":"Paik","year":"2023","journal-title":"Hepatol Commun"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/s41574-021-00507-z","article-title":"Emerging therapeutic approaches for the treatment of Nafld and type 2 diabetes mellitus","volume":"17","author":"Ferguson","year":"2021","journal-title":"Nat Rev Endocrinol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"Easl-Easd-Easo clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (Masld)","volume":"81","year":"2024","journal-title":"J Hepatol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/s41591-023-02242-6","article-title":"Challenges and opportunities in Nash drug development","volume":"29","author":"Harrison","year":"2023","journal-title":"Nat Med"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"118662","DOI":"10.1016\/j.jep.2024.118662","article-title":"Tfeb activator Tanshinone Iia and derivatives derived from Salvia Miltiorrhiza Bge. Attenuate hepatic steatosis and insulin resistance","volume":"335","author":"Zheng","year":"2024","journal-title":"J Ethnopharmacol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"118468","DOI":"10.1016\/j.jep.2024.118468","article-title":"Pueraria Lobata antioxidant extract ameliorates non-alcoholic fatty liver by altering hepatic fat accumulation and oxidative stress","volume":"333","author":"Dong","year":"2024","journal-title":"J Ethnopharmacol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/s42003-021-02883-8","article-title":"Hepatoprotective effects of Cassiae semen on mice with non-alcoholic fatty liver disease based on gut microbiota","volume":"4","author":"Luo","year":"2021","journal-title":"Commun Biol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"967623","DOI":"10.3389\/fphar.2022.967623","article-title":"Chaihu Shugan powder alleviates liver inflammation and hepatic steatosis in Nafld mice: a network pharmacology study and in vivo experimental validation","volume":"13","author":"Lei","year":"2022","journal-title":"Front Pharmacol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2174\/0115734099305489240702075128","article-title":"Network pharmacology and molecular docking integrated with molecular dynamics simulations investigate the pharmacological mechanism of Yinchenhao decoction in the treatment of non-alcoholic fatty liver disease","author":"Yang","year":"2025","journal-title":"Curr Comput Aided Drug Des"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13020-021-00469-4","article-title":"Traditional Chinese medicine in nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives","volume":"16","author":"Dai","year":"2021","journal-title":"Chin Med"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1499602","DOI":"10.3389\/fphar.2024.1499602","article-title":"Application and mechanism of Chinese herb medicine in the treatment of non-alcoholic fatty liver disease","volume":"15","author":"Liu","year":"2024","journal-title":"Front Pharmacol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"4597","DOI":"10.3748\/wjg.v30.i43.4597","article-title":"Potential of traditional Chinese medicine in the treatment of nonalcoholic fatty liver disease: a promising future","volume":"30","author":"Zhang","year":"2024","journal-title":"World J Gastroenterol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"939433","DOI":"10.3389\/fimmu.2022.939433","article-title":"Knowledge mapping of exosomes in autoimmune diseases: a bibliometric analysis (2002-2021)","volume":"13","author":"Wu","year":"2022","journal-title":"Front Immunol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1097\/js9.0000000000001232","article-title":"Knowledge mapping of application of image-guided surgery in prostate Cancer: a bibliometric analysis (2013-2023)","volume":"110","author":"Zeng","year":"2024","journal-title":"Int J Surg"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s11192-009-0146-3","article-title":"Software survey: Vosviewer, a computer program for bibliometric mapping","volume":"84","author":"van Eck","year":"2010","journal-title":"Scientometrics"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"5303","DOI":"10.1073\/pnas.0307513100","article-title":"Searching for intellectual turning points: progressive knowledge domain visualization","author":"Chen","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.joi.2017.08.007","article-title":"Bibliometrix: an R-tool for comprehensive science mapping analysis","volume":"11","author":"Aria","year":"2017","journal-title":"J Informetr"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.1097\/js9.0000000000000492","article-title":"Evolutionary patterns and research Frontiers in neoadjuvant immunotherapy: a bibliometric analysis","volume":"109","author":"Jiang","year":"2023","journal-title":"Int J Surg"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12951-024-02426-3","article-title":"Collision of herbal medicine and nanotechnology: a bibliometric analysis of herbal nanoparticles from 2004 to 2023","volume":"22","author":"Ai","year":"2024","journal-title":"J Nanobiotechnology"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3791\/58494","article-title":"Comparing bibliometric analysis using Pubmed, Scopus, and web of science databases","volume":"152","author":"AlRyalat","year":"2019","journal-title":"J Vis Exp"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/s0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"105849","DOI":"10.1016\/j.phrs.2021.105849","article-title":"Traditional Chinese medicine in the treatment of nonalcoholic steatohepatitis","volume":"172","author":"Chen","year":"2021","journal-title":"Pharmacol Res"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"153544","DOI":"10.1016\/j.phymed.2021.153544","article-title":"Si Miao formula attenuates non-alcoholic fatty liver disease by modulating hepatic lipid metabolism and gut microbiota","volume":"85","author":"Han","year":"2021","journal-title":"Phytomedicine"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1111\/bph.14938","article-title":"Naringenin attenuates non-alcoholic fatty liver disease by down-regulating the Nlrp3\/Nf-\u039ab pathway in mice","volume":"177","author":"Wang","year":"2020","journal-title":"Br J Pharmacol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1107071","DOI":"10.3389\/fendo.2022.1107071","article-title":"The spleen-strengthening and liver-draining herbal formula treatment of non-alcoholic fatty liver disease by regulation of intestinal Flora in clinical trial","volume":"13","author":"Hui","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ctim.2007.08.004","article-title":"The effect of Quyuhuatantongluo decoction on the non-alcoholic steatohepatitis","volume":"16","author":"Zhang","year":"2008","journal-title":"Complement Ther Med"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.26402\/jpp.2024.3.06","article-title":"Does Berberine impact anthropometric, hepatic, and metabolic parameters in patients with metabolic dysfunction-associated fatty liver disease? Randomized, double-blind placebo-controlled trial","volume":"75","author":"Koperska","year":"2024","journal-title":"J Physiol Pharmacol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"105187","DOI":"10.1016\/j.phrs.2020.105187","article-title":"Current policies and measures on the development of traditional Chinese medicine in China","volume":"163","author":"Wang","year":"2021","journal-title":"Pharmacol Res"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/nrgastro.2016.85","article-title":"The role of the gut microbiota in NAFLD","volume":"13","author":"Leung","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.2147\/dmso.S507039","article-title":"Network pharmacology and experimental validation of the effects of Shenling Baizhu san, Quzhi Ruangan Fang and Gexia Zhuyu Tang on the intestinal flora of rats with NAFLD","volume":"18","author":"Guo","year":"2025","journal-title":"Diabetes Metab Syndr Obes"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21155214","article-title":"Gut microbiota metabolites in Nafld pathogenesis and therapeutic implications","volume":"21","author":"Chen","year":"2020","journal-title":"Int J Mol Sci"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"29033","DOI":"10.1021\/acsomega.3c01955","article-title":"Zhuyu pill alleviates nonalcoholic fatty liver disease by regulating bile acid metabolism through the gut-liver Axis","volume":"8","author":"Xu","year":"2023","journal-title":"ACS Omega"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.eng.2022.10.010","article-title":"Pien Tze Huang protects against non-alcoholic steatohepatitis by modulating the gut microbiota and metabolites in mice","volume":"35","author":"Zeng","year":"2024","journal-title":"Engineering"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"114002","DOI":"10.1016\/j.biopha.2022.114002","article-title":"Zuogui-Jiangtang-Qinggan-Fang alleviates high-fat diet-induced type 2 diabetes mellitus with non-alcoholic fatty liver disease by modulating gut microbiome-metabolites-short chain fatty acid composition","volume":"157","author":"Zou","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"e0197923","DOI":"10.1128\/spectrum.01979-23","article-title":"Ling-Gui-Zhu-Gan decoction ameliorates nonalcoholic fatty liver disease via modulating the gut microbiota","volume":"12","author":"Chen","year":"2024","journal-title":"Microbiol Spectrum"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"101052","DOI":"10.1016\/j.jpha.2024.101052","article-title":"Targeting Ampk related signaling pathways: a feasible approach for natural herbal medicines to intervene non-alcoholic fatty liver disease","volume":"15","author":"Cai","year":"2025","journal-title":"J Pharm Anal"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1093\/jpp\/rgaf005","article-title":"Tiaogan Jiejiu Tongluo formula alleviates hepatic steatosis in NAFLD mice by regulating AMPK signaling pathway","volume":"77","author":"Lei","year":"2025","journal-title":"J Pharm Pharmacol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"111162","DOI":"10.1016\/j.cbi.2024.111162","article-title":"Salvianolic acid a attenuates non-alcoholic fatty liver disease by regulating the AMPK-Igfbp1 pathway","volume":"400","author":"Zhu","year":"2024","journal-title":"Chem Biol Interact"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"154798","DOI":"10.1016\/j.phymed.2023.154798","article-title":"Neferine ameliorates nonalcoholic steatohepatitis through regulating AMPK pathway","volume":"114","author":"Wang","year":"2023","journal-title":"Phytomedicine"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"119560","DOI":"10.1016\/j.jep.2025.119560","article-title":"Targeting metabolic diseases with Celastrol: a comprehensive review of anti-inflammatory mechanisms and therapeutic potential","volume":"344","author":"Wang","year":"2025","journal-title":"J Ethnopharmacol"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1080\/13880209.2023.2188549","article-title":"Jianpi-Qinghua formula attenuates nonalcoholic fatty liver disease by regulating the AMPK\/Sirt1\/Nf-\u039ab pathway in high-fat-diet-fed C57bl\/6 mice","volume":"61","author":"Tian","year":"2023","journal-title":"Pharm Biol"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.26599\/fshw.2022.9250200","article-title":"Lignans are the main active components of Schisandrae Chinensis Fructus for liver disease treatment: a review","volume":"13","author":"Fu","year":"2024","journal-title":"Food Sci Human Wellness"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s11154-019-09512-0","article-title":"Dietary lipids, gut microbiota and lipid metabolism","volume":"20","author":"Schoeler","year":"2019","journal-title":"Rev Endocr Metab Disord"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"114985","DOI":"10.1016\/j.biopha.2023.114985","article-title":"Immunological mechanisms of inflammatory diseases caused by gut microbiota Dysbiosis: a review","volume":"164","author":"Zhao","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.cmet.2012.04.001","article-title":"Inflammation and lipid signaling in the etiology of insulin resistance","volume":"15","author":"Glass","year":"2012","journal-title":"Cell Metab"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/mi.2016.75","article-title":"Mechanisms of inflammation-driven bacterial dysbiosis in the gut","volume":"10","author":"Zeng","year":"2017","journal-title":"Mucosal Immunol"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.7150\/thno.30787","article-title":"Berberine in cardiovascular and metabolic diseases: from mechanisms to therapeutics","volume":"9","author":"Feng","year":"2019","journal-title":"Theranostics"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"110984","DOI":"10.1016\/j.biopha.2020.110984","article-title":"Therapeutic effect of berberine on metabolic diseases: both pharmacological data and clinical evidence","volume":"133","author":"Xu","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"118354","DOI":"10.1016\/j.jep.2024.118354","article-title":"Berberine directly targets Akr1b10 protein to modulate lipid and glucose metabolism disorders in Nafld","volume":"332","author":"Yang","year":"2024","journal-title":"J Ethnopharmacol"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.3390\/cells10020210","article-title":"Berberine prevents disease progression of nonalcoholic steatohepatitis through modulating multiple pathways","volume":"10","author":"Wang","year":"2021","journal-title":"Cells"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"1086078","DOI":"10.3389\/fimmu.2023.1086078","article-title":"Targeted modulation of gut microbiota by traditional Chinese medicine and natural products for liver disease therapy","volume":"14","author":"Zhu","year":"2023","journal-title":"Front Immunol"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s12967-024-05011-2","article-title":"The clinical efficacy and safety of Berberine in the treatment of non-alcoholic fatty liver disease: a Meta-analysis and systematic review","volume":"22","author":"Nie","year":"2024","journal-title":"J Transl Med"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"e0134172","DOI":"10.1371\/journal.pone.0134172","article-title":"Efficacy of Berberine in patients with non-alcoholic fatty liver disease","volume":"10","author":"Yan","year":"2015","journal-title":"PLoS One"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"5503","DOI":"10.1038\/s41467-021-25701-5","article-title":"A phase 2, proof of concept, randomised controlled trial of Berberine Ursodeoxycholate in patients with presumed non-alcoholic steatohepatitis and type 2 diabetes","volume":"12","author":"Harrison","year":"2021","journal-title":"Nat Commun"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"117238","DOI":"10.1016\/j.jep.2023.117238","article-title":"Berberine-Silybin salt achieves improved anti-nonalcoholic fatty liver disease effect through regulating lipid metabolism","volume":"319","author":"Ma","year":"2024","journal-title":"J Ethnopharmacol"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27123705","article-title":"Expatiating the pharmacological and Nanotechnological aspects of the alkaloidal drug Berberine: current and future trends","volume":"27","author":"Behl","year":"2022","journal-title":"Molecules"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"1426049","DOI":"10.3389\/fphar.2024.1426049","article-title":"Lingguizhugan Oral solution alleviates Masld by regulating bile acids metabolism and the gut microbiota through activating Fxr\/Tgr5 signaling pathways","volume":"15","author":"Wang","year":"2024","journal-title":"Front Pharmacol"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"2790864","DOI":"10.1155\/2017\/2790864","article-title":"Lingguizhugan decoction protects against high-fat-diet-induced nonalcoholic fatty liver disease by alleviating oxidative stress and activating cholesterol secretion","volume":"2017","author":"Yang","year":"2017","journal-title":"Int J Genomics"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13020-021-00559-3","article-title":"Traditional Chinese medicine Lingguizhugan decoction ameliorate Hfd-induced hepatic-lipid deposition in mice by inhibiting sting-mediated inflammation in macrophages","volume":"17","author":"Cao","year":"2022","journal-title":"Chin Med"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"3590","DOI":"10.3748\/wjg.v25.i27.3590","article-title":"Lingguizhugan decoction attenuates diet-induced obesity and hepatosteatosis via gut microbiota","volume":"25","author":"Liu","year":"2019","journal-title":"World J Gastroenterol"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s11684-021-0880-3","article-title":"Lingguizhugan decoction, a Chinese herbal formula, improves insulin resistance in overweight\/obese subjects with non-alcoholic fatty liver disease: a translational approach","volume":"16","author":"Dai","year":"2022","journal-title":"Front Med"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbad518","article-title":"Network pharmacology: towards the artificial intelligence-based precision traditional Chinese medicine","volume":"25","author":"Zhang","year":"2023","journal-title":"Brief Bioinform"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"107248","DOI":"10.1016\/j.compbiolchem.2020.107248","article-title":"Network pharmacology analysis of Chaihu Lizhong Tang treating non-alcoholic fatty liver disease","volume":"86","author":"Zhang","year":"2020","journal-title":"Comput Biol Chem"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"e35460","DOI":"10.1097\/md.0000000000035460","article-title":"Exploration of potential targets and mechanisms of naringenin in the treatment of nonalcoholic fatty liver disease through network pharmacology","volume":"102","author":"Yu","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20184331","article-title":"Molecular docking: shifting paradigms in drug discovery","volume":"20","author":"Pinzi","year":"2019","journal-title":"Int J Mol Sci"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"156782","DOI":"10.1016\/j.phymed.2025.156782","article-title":"Mechanistic study of a triterpenoid-enriched fraction derived from Cynomorium Songaricum against Nafld: an integrative elucidation","volume":"142","author":"Liu","year":"2025","journal-title":"Phytomedicine"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbad120","article-title":"Machine learning for synergistic network pharmacology: a comprehensive overview","volume":"24","author":"Noor","year":"2023","journal-title":"Brief Bioinform"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1744929\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T06:36:48Z","timestamp":1773988608000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1744929\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,20]]},"references-count":72,"alternative-id":["10.3389\/fmed.2026.1744929"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1744929","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,20]]},"article-number":"1744929"}}